ID: ALA2396938

Max Phase: Preclinical

Molecular Formula: C10H21ClN6

Molecular Weight: 224.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NCCN1CCN=C1C1=NCCN1CCN

Standard InChI:  InChI=1S/C10H20N6.ClH/c11-1-5-15-7-3-13-9(15)10-14-4-8-16(10)6-2-12;/h1-8,11-12H2;1H

Standard InChI Key:  PHWZGCCLJXFRJB-UHFFFAOYSA-N

Associated Targets(Human)

Growth factor receptor-bound protein 2 663 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 224.31Molecular Weight (Monoisotopic): 224.1749AlogP: -1.67#Rotatable Bonds: 5
Polar Surface Area: 83.24Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.58CX LogP: -2.15CX LogD: -4.23
Aromatic Rings: 0Heavy Atoms: 16QED Weighted: 0.58Np Likeness Score: -0.33

References

1. Simister PC, Luccarelli J, Thompson S, Appella DH, Feller SM, Hamilton AD..  (2013)  Novel inhibitors of a Grb2 SH3C domain interaction identified by a virtual screen.,  21  (14): [PMID:23182216] [10.1016/j.bmc.2012.10.023]

Source